LYMPHOMAINFO.NET: Keyword Density Checker

Total words: 3759 | 2-word phrases: 978 | 3-word phrases: 1115 | 4-word phrases: 1165

PAGE INFO

Title	Try to keep the title under 60 characters (28 characters) Lymphoma Information Network
Description	Try to keep the meta description between 50 - 160 characters (104 characters) Lymphoma Information is a place to learn about lymphoma treatment, symptoms, causes, prognosis and more.
Keywords	Meta keywords are not recommended anymore (104 characters) lymphoma information
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	research and education	8	0.72%
2	the us food	4	0.36%
3	has announced that	3	0.27%
4	information about diabetes	3	0.27%
5	food and drug	3	0.27%
6	us food and	3	0.27%
7	merkel cell carcinoma	3	0.27%
8	chronic lymphocytic leukemia	3	0.27%
9	phase iii trial	3	0.27%
10	bcell lymphoma types	2	0.18%
11	treatment for lymphoma	2	0.18%
12	bcell bcell lymphoma	2	0.18%
13	indepth list of	2	0.18%
14	and drug administration	2	0.18%
15	lymphoma therapy radiotherapy	2	0.18%
16	radiotherapy lymphoma therapy	2	0.18%
17	lymphoma site map	2	0.18%
18	immunotherapy emerging as	2	0.18%
19	and education ash	2	0.18%
20	education ash 2013	2	0.18%
21	lymphoma is a	2	0.18%
22	the pathophysiology of	2	0.18%
23	cell carcinoma and	2	0.18%
24	education in association	2	0.18%
25	nonhodgkin’s lymphomas nhl	2	0.18%
26	in association with	2	0.18%
27	nonhodgkin’s lymphomas nhls	2	0.18%
28	association with amazoncom	2	0.18%
29	leukemia merkel cell	2	0.18%
30	for the investigational	2	0.18%

#	Keyword	Frequency	Density
1	us food and drug	3	0.26%
2	the us food and	3	0.26%
3	follicular europeans begin formal	2	0.17%
4	is a general term	2	0.17%
5	three papers look at	2	0.17%
6	efficacy of idelalisib in	2	0.17%
7	of idelalisib in cll	2	0.17%
8	diffuse large b cell	2	0.17%
9	in cll inhl and	2	0.17%
10	cll inhl and mcl	2	0.17%
11	lymphoma is a general	2	0.17%
12	designation for the investigational	2	0.17%
13	a general term for	2	0.17%
14	search page site information	2	0.17%
15	bcell bcell lymphoma types	2	0.17%
16	and education ash 2013	2	0.17%
17	the pathophysiology of lymphoma	2	0.17%
18	research and education ash	2	0.17%
19	has announced that the	2	0.17%
20	europeans begin formal review	2	0.17%
21	begin formal review of	2	0.17%
22	bcell three papers look	2	0.17%
23	idelalisib in cll inhl	2	0.17%
24	prognosis diffuse large b	2	0.17%
25	in association with amazoncom	2	0.17%
26	leukemia merkel cell carcinoma	2	0.17%
27	phase iii trial for	2	0.17%
28	therapeutics ever go away?	2	0.17%
29	radiotherapy lymphoma therapy radiotherapy	2	0.17%
30	merkel cell carcinoma and	2	0.17%
31	nonhodgkins lymphoma nonhodgkins lymphoma	2	0.17%
32	symptoms treatment surviving lymphoma	2	0.17%
33	education in association with	2	0.17%
34	submits nda for ibrutinib	1	0.09%
35	lymphoma pharmacyclics submits nda	1	0.09%
36	for the investigational agent	1	0.09%
37	pharmacyclics submits nda for	1	0.09%
38	against mcl and sll	1	0.09%
39	nda for ibrutinib against	1	0.09%
40	for ibrutinib against mcl	1	0.09%

#	URL	Whois	Check